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Abstract: In this work we developed a plasma source based on a Plasma Gun reactor able 
to generate small quantities of CO. The production fraction of CO molecules has been 
measured ex-situ by means of gas chromatography. We showed that the density is in the 100 
– 10000 ppm range. The CO concentration can be controlled by varying the gas mixture and 
by tuning the applied voltage. In CO clinical application, the typical dose used is in the range 
of 100 -1000 ppm. It means that this plasma reactor is suitable as CO source for biological 
applications. 
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1. Introduction 
Carbon monoxide (CO) is well known for its toxic 
effects at high doses. The effects of CO can be quantified 
via the percentage of carboxyhemoglobin (COHb) forms in 
the blood. The percentage of COHb in blood strongly 
depends not only on the percentage of CO in air, but also 
on the exposure time. However, CO is also naturally 
produced at cellular level, mostly via the catabolism of 
heme. At low doses, CO has therapeutic properties. 
Experimental studies found several positive effects of CO 
such as anti-inflammatory, vasodilatory and anti-apoptotic 
effects. It has also an influence on plants and promote the 
seed germination and increases the roots formation [1], [2]. 
In this context, non-equilibrium plasma at atmospheric 
pressure is an attractive in situ CO source, since it is able 
to create CO at low concentration from CO2. This has the 
advantage to alleviate the risk related to CO storage.  
Additionally, atmospheric pressure plasma can be used 
for biomedical applications. It has been demonstrated that 
plasma has antitumor and cell regeneration effects [3], [4]. 
The combination of plasma and CO could have then 
synergetic effects.  
This contribution focuses on the challenge to develop a 
plasma reactor able to produce controlled small quantities 
of CO for biomedical applications.    
2. Experimental set-up 
The plasma reactor is based on a Plasma Gun device. The 
primary discharge is produced in a coaxial dielectric barrier 
discharge (DBD) reactor equipped with a quartz capillary 
tube. A schematic of this reactor is shown on Figure 1. 
Inside the 4 mm inner diameter tube is inserted a ring 
electrode connected to the high voltage, while a second 
ring electrode placed around the tube is connected to the 
ground. The two electrodes are separated by a 1 mm gap. 
The quartz tube is connected to a cylindrical cell of a 
40 mm diameter and 40 mm high. A third electrode 
wrapped at the end of the cell is connected to the ground.  
In this work, the device was powered by microsecond-
duration voltage pulses from 10 to 20 kV with a repetition 
frequency between 1 kHz to 20 kHz. 
The gas flow rate was set between 50 – 2000 standard 
cubic centimeters per minute (sccm) is used. The 
experiments were performed at atmospheric pressure in 
helium as buffer gas with small quantities of CO2 varying 
ratios from 0.5 to 10%. 
 
 
Figure 1: Schematic (left) and picture of the plasma 
reactor (right). 
 
In order to mimic the biological application conditions, 
the cell was half-filled of wheat seeds (approximately 
250 seeds).  
The CO fraction in the effluent of the reactor is measured 
by an ex-situ gas analyser method with a gas 
chromatograph. 
3. Results and discussions 
The quantity of CO was measured as a function of the 
CO2 percentage in the exhaust gas mixture. For the typical 
results plotted in Figure 2, the total gas flow was 500 sccm, 
the applied voltage was 15 kV and the repetition frequency 
5 kHz. As it can be seen, only small quantity of CO2 are 
necessary to form significant amounts of CO, but 
percentages higher than 1.0 % lead to a decrease of the 
produced concentrations.  
The production lies in the 400 – 1200 ppm range and 
corresponds to the dose usually used in CO clinical 
applications [2], showing that this plasma can be suitable 
use as CO source for biomedical applications.  
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Figure 2: CO fraction as a function of the CO2 percentage. 
The total gas flow is 500 sccm. The applied voltage is 
15kV, and the repetition frequency 5kHz.  
Figure 3 shows, in a log scale, the CO measured fraction 
in the gas effluent as a function of the applied voltage for 
500 sccm of He and 1% of CO2. In the present graph the 
trend follows a quasi-linear law indicating that the 
produced CO quantity increases according to an 
exponential-law.  
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Figure 3: CO density as a function of the applied voltage in 
log-log scale. The gas flow is 500 sccm of He with 1% of 
CO2 and the repetition frequency is 5kHz.  
4. Conclusion 
In the work we developed a plasma source based on a 
Plasma Gun reactor able to produce small quantities of CO 
ranging between 100 – 10000 ppm. The fraction of CO 
molecules has been measured ex-situ by means of gas 
chromatography. The produced CO fraction can be easily 
controlled by varying the gas mixture and by tuning the 
applied voltage.  
In CO clinical application, the typical dose used is in the 
range of 100 -1000 ppm. It means that this plasma reactor 
is clearly suitable as CO source in that domain and for other 
biological applications. 
5. References 
[1] E. Carbone & C. Douat, Plasma Med., vol. 8, no. 
1, 93–120, (2018). 
[2] R. Foresti, M. G. Bani-Hani, et al., Intensive Care 
Med., vol. 34, no. 4, 649–658, (2008). 
[3] M. Vandamme, E. Robert, et al., Plasma Med., vol. 
1, no. 1, 27–43, (2011). 
[4] S. Vandersee, H. Richter, et al., Laser Phys. Lett., 
vol. 11, no. 11, 115701, (2014). 
[5] S. Ponduri, M. M. Becker, et al., J. Appl. Phys., 
vol. 093301, (2016). 
[6] F. Brehmer, S. Welzel, et al., J. Appl. Phys., vol. 
116, no. 12, 123303, (2014). 
 
